Delivery Order SPE2DR25D2007-SPE2DR26FM13A
- Not listed
- The Defense Logistics Agency (DLA) awarded a $2,744.80 delivery order to AmerisourceBergen Drug Corp for Naltrexone 50 mg tablets (100-count units) with an ultimate completion date of November 10, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a standard pharmaceutical procurement supporting federal medical supply requirements. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $47,260.15 to AmerisourceBergen Drug Corp for the supply of Naltrexone 50 mg tablets in quantities of 60 units. The contract, executed on August 5, 2025, with an ultimate completion date of August 6, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Naltrexone 50 mg tablets (100-count units) with a contract ceiling value of $1,700.58. This firm fixed-price delivery order, which is set to be completed by October 31, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award was...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $40,872.08 to AmerisourceBergen Drug Corp for the supply of Naltrexone 50 mg tablets in quantities of 60 units. The contract, awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order through its Corporate Office division and performed work...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Naltrexone 50 mg tablets in quantities of 60 units, with a ceiling value of $12,745.23. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by September 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Naltrexone 50 mg tablets in quantities of 60 units. This competitively awarded, non-set-aside contract has a ceiling value of $3,275.92 and is structured as a firm fixed-price delivery order with a completion date of November 5, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Naltrexone 50 mg tablets in quantities of 100 units, with a ceiling value of $11,183.99 and an ultimate completion date of November 7, 2025. This competitive, firm fixed-price delivery order was issued without set-aside designation and is to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine...
- The Defense Logistics Agency awarded a $2,397.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Naltrexone 50 mg tablets (100-count units), with an ultimate completion date of June 2, 2025. This non-set-aside contract represents a competitive award to the pharmaceutical distributor's Corporate Office located in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Naltrexone 50 mg tablets in quantities of 60 units. This firm fixed-price delivery order, valued at $1,782.75, represents a non-competitive, non-set-aside award with an ultimate completion date of July 25, 2025. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The U.S. Defense Logistics Agency (DLA) awarded a $29,831.08 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp. to supply 60-count Naltrexone 50 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical, which enables DLA to efficiently procure a wide range of pharmaceutical and medical supplies to support military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor, holds...
- SPE2DR25D2007Indefinite Delivery Contract
- SPE2DR25D2007-SPE2DR26FM13ADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Naltrexone 50 mg tablets (100-count packages) under a firm fixed-price contract valued at $5,663.10, with an ultimate completion date of November 17, 2025. The award, announced on November 14, 2025, was competitively awarded with no set-aside designation. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare systems. The company maintains an extensive portfolio of federal pharmaceutical contracts with the DLA, supplying a comprehensive range of medications, vaccines, and medical supplies across multiple therapeutic domains. The current delivery order for Naltrexone, an opioid antagonist medication, aligns with the company's established role as a primary vendor for pharmaceutical procurement supporting the Defense Health Agency and other federal healthcare customers through the broader pharmaceutical supply chain vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 11/14/25 |